News

It’s illegal to advertise prescription drugs. Novo Nordisk, which makes Ozempic and Wegovy, has not named any drugs in its ...
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...
Amanda Rodriguez felt exceptionally proud as she ran the Chicago Marathon last fall. She also felt a touch weighed down. With other races on the horizon, she decided to go back on tirzepatide ...
A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...
Apple has posted a new iPhone 16 ad spot online The clip shows off the toughened Ceramic Shield glass A case is probably still a good idea though Apple's ad spots are always polished, thoughtfully ...
Novo Nordisk sells semaglutide under the brands Wegovy and Ozempic for weight loss and type 2 diabetes treatment respectively. Image credit: Getty/UCG. A US judge has rejected efforts by a compounded ...
Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...
To be included on the map, you must submit your garage sale ad to Newscow by Thursday, April 24, at 4 p.m. You will not be included on the map after that deadline, although you can still advertise on ...
Delhi Transport Corporation (DTC) officials confirmed that no advertising space has been allotted ... DEVI buses also offer free rides to women through pink tickets. The buses are powered by ...